Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.

INTRODUCTION The ICHS7B guideline focused on hERG and QT assays, although other factors have also been linked with the induction of severe arrhythmias. Thus, the aim of the present study was to demonstrate that two in vitro action potential recordings constitute convincing models of predictive drug-induced Torsades de pointes (TdP) and re-entry arrhythmias. METHODS The effects of D,L-sotalol, flecainide and quinidine were investigated on potassium (hERG) and sodium (Na(V)1.5) currents transfected in HEK-293 cells to determine the repercussion of the blockade of these currents on rabbit Purkinje fibre (PF) and atrial action potentials. Atrial conduction velocity was also investigated as a model of re-entry arrhythmias. RESULTS hERG channels were blocked by D,L-sotalol, quinidine and flecainide (IC(50): 69, 0.33 and 0.74 micromol/L, respectively). D,L-sotalol (30 micromol/L) induced reverse-use dependent increases in action potential duration (APD(90): +31.7% and +81.2% at 1 and 0.2 Hz) and triangulation (APD(90-40): +34.7% and +73.6% at 1 and 0.2 Hz) in PF but not in atria. Quinidine (10 micromol/L) also increased APD(90) (+14.5% and +68.5% at 1 and 0.2 Hz) and APD(90-40) (+73.3% and +152.1% at 1 and 0.2 Hz) in PF. Flecainide (10 micromol/L) shortened APD(90) in PF (-26.0% and - 22.2% at 1 and 0.2 Hz). Quinidine and flecainide blocked Na(V)1.5 channels by 32.3% and 73.1%, respectively, and produced decreases in dV/dt(max) which were more marked in atria (-20.4% and -31.9%) compared to PF (-12.8% and 22.4%) at 1 Hz. Finally, quinidine and flecainide decreased atrial conduction speed by 14.6% and 30.8%, respectively. CONCLUSION Results obtained with flecainide demonstrate that use of the hERG channel alone should not be considered as a useful single assay. Rabbit Purkinje fiber action potentials can be considered as a comparable model for detection of reverse-use dependent APD prolongation and triangulation whereas the rabbit atria can be considered as a useful model for detection of sodium channel blockade associated with decreases in dV/dt(max) and conduction velocity.

[1]  H A Fozzard,et al.  The relation of Vmax to INa, GNa, and h infinity in a model of the cardiac Purkinje fiber. , 1979, Biophysical journal.

[2]  P. Hoffmann,et al.  Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends. , 2006, Journal of pharmacological and toxicological methods.

[3]  Hua-rong Lu,et al.  Drug-induced long QT in isolated rabbit Purkinje fibers: importance of action potential duration, triangulation and early afterdepolarizations. , 2002, European journal of pharmacology.

[4]  W. Crumb,et al.  Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias , 2000, Expert opinion on pharmacotherapy.

[5]  C. Starmer,et al.  Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells. , 2000, Biophysical journal.

[6]  M. Sanguinetti,et al.  hERG potassium channels and cardiac arrhythmia , 2006, Nature.

[7]  L. Horowitz,et al.  Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. , 1984, The American journal of cardiology.

[8]  M. Omata,et al.  Regional differences in transient outward current density and inhomogeneities of repolarization in rabbit right atrium. , 1995, Circulation.

[9]  Jian-An Yao,et al.  Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells. , 2006, Journal of pharmacological and toxicological methods.

[10]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[11]  A. Camm,et al.  Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.

[12]  J. Shryock,et al.  Use of preclinical assays to predict risk of drug-induced torsades de pointes. , 2005, Heart rhythm.

[13]  D. Fedida,et al.  The Role of Late INa and Antiarrhythmic Drugs in EAD Formation and Termination in Purkinje Fibers , 2006, Journal of cardiovascular electrophysiology.

[14]  L. D. Davis,et al.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1985, Journal of the American College of Cardiology.

[15]  P. Kirchhof,et al.  Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects. , 1998, Circulation.

[16]  R. Shah,et al.  Refining detection of drug-induced proarrhythmia: QT interval and TRIaD. , 2005, Heart rhythm.

[17]  Richard Printemps,et al.  Additive effects of ziprasidone and D,L-sotalol on the action potential in rabbit Purkinje fibres and on the hERG potassium current. , 2005, Journal of pharmacological and toxicological methods.

[18]  M. Hoffmann,et al.  Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve. , 2006, Journal of pharmacological and toxicological methods.

[19]  Hua-rong Lu,et al.  Species Plays an Important Role in Drug‐Induced Prolongation of Action Potential Duration and Early Afterdepolarizations in Isolated Purkinje Fibers , 2001, Journal of cardiovascular electrophysiology.

[20]  J. Valentin,et al.  Nonclinical proarrhythmia models: predicting Torsades de Pointes. , 2005, Journal of pharmacological and toxicological methods.

[21]  Gary A Gintant,et al.  The Utility of hERG and Repolarization Assays in Evaluating Delayed Cardiac Repolarization: Influence of Multi-Channel Block , 2004, Journal of cardiovascular pharmacology.

[22]  Ard Teisman,et al.  Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit. , 2005, Journal of pharmacological and toxicological methods.

[23]  D. Potreau,et al.  Endothelin-1 inhibits L-type Ca2+ current enhanced by isoprenaline in rat atrial myocytes. , 1997, Journal of cardiovascular pharmacology.

[24]  P. Hoffmann,et al.  Blinded Test in Isolated Female Rabbit Heart Reliably Identifies Action Potential Duration Prolongation and Proarrhythmic Drugs: Importance of Triangulation, Reverse Use Dependence, and Instability , 2003, Journal of cardiovascular pharmacology.

[25]  C. Gibbs,et al.  Papillary muscles split in the presence of 2,3-butanedione monoxime have normal energetic and mechanical properties. , 1995, The American journal of physiology.

[26]  G. Duker,et al.  Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic , 2001, Circulation.

[27]  S Nattel,et al.  The Molecular and Ionic Specificity of Antiarrhythmic Drug Actions , 1999, Journal of cardiovascular electrophysiology.

[28]  Comparative Effects of Clarithromycin on Action Potential and Ionic Currents from Rabbit Isolated Atrial and Ventricular Myocytes , 2003, Journal of cardiovascular pharmacology.

[29]  A H Glassman,et al.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.

[30]  J. Hancox,et al.  Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine , 2002, British journal of pharmacology.

[31]  C. January,et al.  Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. , 1999, Circulation research.

[32]  Charles Antzelevitch,et al.  Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. , 2005, Heart rhythm.

[33]  R. Lazzara From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. , 1996, The American journal of cardiology.

[34]  D. Saint,et al.  BLOCK OF Na+ AND K+ CURRENTS IN RAT VENTRICULAR MYOCYTES BY QUINACAINOL AND QUINIDINE , 2005, Clinical and experimental pharmacology & physiology.

[35]  Charles Antzelevitch,et al.  Assessing predictors of drug-induced torsade de pointes. , 2003, Trends in pharmacological sciences.

[36]  J. Tamargo Drug-induced torsade de pointes: from molecular biology to bedside. , 2000, Japanese journal of pharmacology.